Inflammation Signals
KPV is studied for how it may quiet chemical messages that drive inflammation.
KPV is a three-amino-acid fragment of the natural hormone alpha-MSH. Researchers use cell and animal models to study how it moves through surface cells and affects signals linked with inflammation, including in protective linings.
At a glance
KPV is studied for how it may quiet chemical messages that drive inflammation.
Researchers study how KPV enters cells lining the intestines and affects their response to irritation.
It may affect messages released by immune cells during inflammation.
Animal research has examined how KPV may affect recovery of protective surface cells, including the eye's outer layer.
Available separately for laboratory use.
Open the document and check that its product and batch details match your item.
This document applies only to the product and batch printed on it.
Read the supporting laboratory, animal and human research. This section does not provide instructions for human or veterinary use, diagnosis, treatment, prevention, dosage or administration.
KPV is a small peptide made from lysine, proline and valine. It matches the end section of alpha-melanocyte-stimulating hormone, often shortened to alpha-MSH. Researchers use KPV to study how this small fragment behaves without the full hormone. Current sources focus on cell transport, inflammatory signals and protective surface cells.
Normal target and function. KPV is studied in relation to PepT1, a transporter that normally moves small peptides across some epithelial cells. Researchers also measure NF-kB and cytokines, which are normal signalling systems cells use to coordinate inflammatory responses. A single direct KPV receptor has not been confirmed.
One research question is how KPV crosses epithelial cells, the cells that form surfaces and barriers. Intestinal studies have examined a transporter called PepT1, which moves small peptides into cells. Researchers then measure signals such as NF-kB and cytokines, which help coordinate inflammation. Other work uses eye-surface injury models. Researchers also check whether the fragment remains intact during each experiment.
Cell studies examine whether PepT1 moves KPV across intestinal surface cells.
Researchers measure NF-kB and cytokines, signals involved in cell responses to stress.
Work includes epithelial cells that form protective layers in the intestine and cornea.
KPV is studied as a small part of alpha-MSH, not as the complete hormone.
Intestinal cell work has reported PepT1-dependent transport and changes in inflammatory signals. Animal eye-surface and inflammation models have reported changes in epithelial endpoints after controlled injury. These are preclinical observations and do not demonstrate an effect in people.
Measurements used in these studies
The linked evidence comes from intestinal cells and animal surface-tissue models. It does not show whether KPV produces the same signals or any noticeable effect in people.
Reliable human safety information for KPV is not available, so a product-specific adverse-effect list cannot be supported.
| Evidence type | What was studied | How much evidence | What this means |
|---|---|---|---|
| Laboratory research | Intestinal cell models | Preclinical | Studies examined peptide transport and changes in inflammatory signals. |
| Animal research | Corneal and inflammation models | Preclinical | Animal work measured surface-cell endpoints after controlled injury. |
| Human research | Controlled clinical studies | Not established | The sources linked on this page do not contain meaningful controlled human research for KPV. |